Immunotherapy for Early Stage Colorectal Cancer: A Glance into the Future

Immune checkpoint inhibitors (ICI) have reshaped therapeutic strategies for cancer patients. The development of ICI for early stage colorectal cancer is accompanied by specific challenges: (i) the selection of patients who are likely to benefit from these treatments, i.e., patients with tumors harbo...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Romain, Shi, Qian, André, Thierry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409300/
https://www.ncbi.nlm.nih.gov/pubmed/32708216
http://dx.doi.org/10.3390/cancers12071990

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409300/
https://www.ncbi.nlm.nih.gov/pubmed/32708216
http://dx.doi.org/10.3390/cancers12071990

Ejemplares similares